Navigation Links
NHP Reports Second Quarter 2008 Earnings
Date:8/6/2008

,156,500 1,166,500

Notes and bonds payable 386,314 340,150

Accounts payable and accrued

liabilities 133,634 107,844

Total liabilities 1,676,448 1,655,494

Minority interest 52,871 6,166

Stockholders' equity:

Series B convertible preferred stock 106,410 106,445

Common stock 9,660 9,481

Capital in excess of par value 1,621,224 1,565,249

Cumulative net income 1,494,220 1,288,751

Accumulated other comprehensive

income 2,320 2,561

Cumulative dividends (1,578,578) (1,489,794)

Total stockholders' equity 1,655,256 1,482,693

Total liabilities and

stockholders' equity $3,384,575 $3,144,353


'/>"/>
SOURCE Nationwide Health Properties, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. AMN Healthcare Reports Second Quarter 2008 Results
2. Dialysis Corporation of America Reports Second Quarter 2008 Results
3. MedCath Corporation Reports Third Quarter Earnings
4. Hospira Reports Second-Quarter 2008 Results
5. PLC Systems Reports Second Quarter 2008 Results
6. Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008
7. Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million
8. Endocare Reports Financial Results for Second Quarter 2008
9. P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth
10. Metropolitan Health Networks Reports 2008 Second Quarter Results
11. NxStage Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... HealthDay Reporter TUESDAY, Dec. ... fast approaching, a new study reveals that states that routinely ... drunk drivers on their roads. The finding suggests that ... able to deter inebriated revelers from getting behind the wheel ... being passed regarding drinking and driving," said study lead author ...
(Date:12/15/2014)... Cancer researchers have just published an ... of deadly malignant pleural mesothelioma. Surviving Mesothelioma has just ... Click here to read it now. , ... Center, and New York’s Langone Medical Center performed complete ... in an effort to pinpoint the genes that ...
(Date:12/15/2014)... SIMpalm, a leading mobile app development company , ... client, which allows users to keep track of wines ... the right wine. At the center of WineMatch ... and wine information. All this information is assembled to ... that are close counterparts to one another are called ...
(Date:12/15/2014)... SUNDAY, Dec. 14, 2014 (HealthDay News) -- Expert pilots ... which explains why they make better decisions during landings, ... the most difficult techniques for pilots to master, and ... of fatal crashes occur during final approach and landing. ... pilots and 12 moderately experienced pilots while they were ...
(Date:12/15/2014)... 15, 2014 In support of ... attention to restrictive state laws that may have ... this important area of public health policy. , ... the Integrity of Independent Review, contends that state ... independent peer review determinations can result in subpar ...
Breaking Medicine News(10 mins):Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
... geared to genetic blueprints from Elite Books, TUCSON, Ariz., ... It,plays a key role in the development of Alzheimer,s Disease ... it is greatly affected,by diet. In her seminal book, ... Heart and Alzheimer,s Using the Body,s Own Genes,(Elite, Hardcover, $27.95, ...
... FRAMINGHAM, Mass., Nov. 5 StatSure Diagnostic,Systems, Inc. ... U.S.,Food and Drug Administration ("FDA"), through its Center ... under the Clinical Laboratory,Improvements Amendments of 1988 ("CLIA") ... patented "barrel" technology. The HIV 1/2 product,is marketed ...
... to place systems in more physician offices could ... of underserved patient populations, NEW YORK, Nov. 5 ... New York (HIP) will convene an educational seminar in,New ... treating,underserved patient populations. The seminar, to be held at ...
... Research Findings to Impact Human Health, Agricultural Science, ... Beauty announced that they successfully sequenced the complete ... fungus,responsible for the onset of dandruff and other ... are published in today,s online edition of,Proceedings of ...
... 5 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... Suisse Healthcare Conference will be webcast live and,may ... the Company,s website, http://www.millennium.com . (Logo: ... an overview of the Company, an update on,clinical ...
... to Compulsory Acquisition, WARSAW, Ind. and MONTREAL, Nov. ... ZMH), a leader in the orthopaedics,industry, and its indirect ... pursuant to the extension of the Offer,made for all ... a leader in computer navigation for orthopaedic,surgery, it has ...
Cached Medicine News:Health News:Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 3Health News:GHI and HIP Lead Effort to Expand Electronic Health Record System Throughout the City of New York 2Health News:Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders 2Health News:Photo: Scientists Complete Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders 3Health News:2007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 2Health News:Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid 2Health News:Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid 3
(Date:12/17/2014)... STUTTGART, Germany , December 17, 2014 ... high level of expenditure on research and development ... ZEISS increased its revenue by two percent to EUR 4.287 ... Earnings (EBIT) grew by 14 percent to EUR 360 million. ... Group," said Dr. Michael Kaschke , President and CEO ...
(Date:12/17/2014)... Dec. 17, 2014  Beamz Interactive, Inc. (OTCQB: ... products, today announced that it has signed an ... and supplier of innovative prosthetic, orthotic and assistive ... of the agreement, RSL Steeper will promote and ... configured for use within UK residential care facilities ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals Corporation ... focused on discovering, developing and commercializing innovative therapies ... today announced completion of enrollment in its first Phase ... 3-month observations confirmed the 1-month findings that were ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... Eisai Corporation of North,America announced today that ... the company,s oncology pipeline, product portfolio and,preclinical oncology ... Annual Meeting of the American Society of Clinical ... to June 3, 2008., A wide variety ...
... FRANCISCO, May 15 Medivation, Inc.,(Nasdaq: MDVN ) ... clinical,trial of its novel androgen receptor antagonist, MDV3100, will ... Society of Clinical Oncology,(ASCO) Annual Meeting in Chicago., ... Prostate Cancer Session date and time: Monday, June ...
Cached Medicine Technology:Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
2 mm wide x 3 mm long, with rounded triangular tip. Angled 45 degrees. Hexagonal handle....
Duckbill type sharp. 3 mm wide x 8 mm long curved blade. Octagonal handle....
9 mm slightly curved blade. Hexagonal handle....
Medicine Products: